Research Article
Fibrin Clot Strength in Patients with Diabetes Mellitus Measured by Thrombelastography
Table 2
Thrombelastography measures.
| | No diabetes mellitus () | Diabetes mellitus () | value |
| Plasma TEG-R (min) | 6.9 ± 3.8 | 6.6 ± 3.0 | 0.36 | Plasma TEG-K (min) | 1.47 ± 1.2 | 1.38 ± 1.3 | 0.49 | Plasma TEG-MA (mm) | 34.1 ± 7.5 | 37.0 ± 8.1 | <0.001 | Whole blood TEG-R (min) | 5.1 ± 2.2 | 5.6 ± 1.6 | 0.26 | Whole blood TEG-K (min) | 1.5 ± 0.5 | 1.58 ± 0.5 | 0.45 | Whole blood TEG-MA (mm) | 66 ± 5.8 | 66.6 ± 5.6 | 0.61 |
|
|
TEG-R = time to fibrin formation; TEG-K = clot formation time; TEG-MA = maximal clot strength. Plasma TEG: . Whole blood TEG: . |